DOCSLIB.ORG

159 2004 & 2005 Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

VOLUME XIV, NUMBER 2 WINTER SOLSTICE 2005 Agilent series 1100 HPLC 113 Aquinas, Saint Thomas 36 aguardiente 140 argon 94 2004 & 2005 INDEX Aisner, RafaelO 119 Argyreia nervosa 103, 112 al-Uzza 35 Ariocarpus species 147 Alatriste, Pedro 21 Aromacare (vaporizer) 56 1,2-dimethyl-1,2,3,4-tetrahydrobeta- Albert Hofmann Foundation 153 Aromazap (vaporizer) 57 carboline 115, 117 alcohol 10, 42, 46, 49, 53, 57, 107, 108 Aromed 29 12-hydroxyibogamine 10 aldose-reductase-inhibitor 54 Arrazola 66, 68 1,4-butanediol 123 alebrijes 66, 67 art, blotter 153, 158 18-methoxycoronaridine 10 Alex 62 art, psychedelic 12 β 2-methyl-1,2,3,4-tetrahydro- - Alice in Wonderland 70 Artemis 37 carboline 112 Alipieva, K.I. 54 Artemisia species 107 24-epi-pterosterone 54 aloe vera 107 Artemisia abrotanum 107 2C-B 46, 120, 146, 147, 148, 149 alpha-beta-thujone (also see “thujone”) Artemisia absinthium 106, 107, 108 2C-E 123 108 Artemisia dracunculus 107 2C-I 123, 124 alpha-thujone (also see “thujone”) 108 arthritis pain 147 2C-T-2 123 Altoid 25 Aspergillus alliaceus 151 2C-T-4 146 Alzheimer’s disease 23 asperlicin 151 2C-T-7 94 Amaringo, Pablo 29 ass-huasca 46 5-HO-DMT (also see bufotenine) 109 Amazon 29, 30 associated anxiety disorder 86 5-MeO-AMT 27 American Chemical Supply 58 asthma 2 5-MeO-DALT 27, 28 amitriptyline 111 AT Verlag 110 5-MeO-DIPT 46, 147 amphetamine 23, 54, 84 ataxia 7 5-MeO-DMT 46, 57, 109, 111, 123, AMS Research 123 Attisani, Dominick 73 149, 150, 151 AMT 27, 122 aura 102 Australian National University A Anadenanthera species 41, 46, 53, 57, 63 109, 114 autism/autistic 17, 63, 69, 74 Aguirre, Rodolfo Tinoco 21 Anadenanthera colubrina 26, 27, 53, 57 AVS Journal 156 “A Framework for Action” 11 Anadenanthera peregrina 55 ayahuasca 26, 27, 29, 30, 54, 55, 84, Aardvark, David 81, 109, 111, 112, Anadenanthera seed-enema 109 85, 90, 91, 121, 134, 135, 136, 137, 126 analgesic 54, 111 139, 140, 141, 146, 152 “Absence” (hypothetical sage-based androstenedione 108 Ayahuasca Healing Retreat 152 liquor) 106, 108 angels 61 Ayahuasca-Wasi 30 Absente (U.S.-produced absinthe) 107 animism 35 Ayensu, E.S. 54 absinthe 106, 108 anise 106 Aztec sulfur magnets 62 Absorbine 108 Anonymous, IN 27 abstinence 25 anthropomorphism 35 B anti-inflammatory 111 Acacia species 35, 112, 113, 114, 115, Baldung, Hans Grien 32 antibacterial 54 117, 118 Bautista, Francisco Carrillo 130 anticonvulsant 111 Acacia complanata 113, 115 β-carboline(s) 113, 115, 116 antidepressant 6, 111, 126, 147 Acacia confusa 115 B. Green, NM 26, 56 antifeedant 54 Acacia farnesiana 112 B.C. Vaporizer 57 antifungal 105 Acacia intertexta 115 Bächtold-Stäubli, H. 36 antihepatotoxic 54 Acacia maidenii 113, 114, 115 Badrak, Beth 59 antihypertensive 54, 111 Acacia obtusifolia 113, 114, 115, 116, 117 Bandow, Christine 31 antiinflammatory 54 Acacia phlebophylla 113, 115 Banisteriopsis caapi 56 antileukemic 54 Acacia simplex 115 Barrau, Jacques 104 antinociceptive 147 acetonitrile 113 Barrett, Deirdre 64, 72 Acevedo, Michael antioxidant 54 146 Barron, Frank 18, 19 antipsychotic 147 Achillea millefolium 107 Basement Shaman, The 26, 55 antipyretic 111 acid, citric 50 Bastiaans, Jan 87 antirheumatic 54 acid, hydrochloric 50 Baudelaire, Charles 14 antiseptic 54, 108 acid, muriatic 50 Bauer, Wolfgang 29, 36 antistaph 54 acupuncture 62 BC Marijuana Party 96, 97, 99, 101 Adderall antitumor 54 125 Beatles (the band) 27 ants 53 addiction 1 Beckmesser, Sixtus 34 anxiety 88 addicts 11 Behringer, Wolfg. 34 Adorno, Theodor aphids 53, 56 37 benactizine 16 Aphrodite 37 agara (also see Galbulimima belgraveana) Benda, Clemens C. 16 104, 105 Appleton, Alistair 152 THE ENTHEOGEN REVIEW, POB 19820, SACRAMENTO, CA 95819-0820, USA 159 VOLUME XIV, NUMBER 2 WINTER SOLSTICE 2005 Bender-Gestalt test 15 Buddha 35 chloroform 55 Benjamin, Walter 14 Buddhist 20 chocolate 72, 109 Benson, Elizabeth 41, 42 bufotenine 57, 109, 115, 116, 117 cholecystokinin 151 benzene 64 Bumb, Geneva 120, 132 cholecystokinin inhibitor 151 benzodiazepine 24, 87, 151 Bunnell, Sterling 19 Chonhuber, Lili 36, 37, 38 Berger, Markus 29 buprenorphine 11 Chopra, R.N. 54 Beringer, Kurt 12, 13 Burka, Thomas 107 Christ (also see Jesus) 19 Berlin, Louis 15 Burning Man 43, 61, 62, 64, 119, 120 Christian 52, 85 Bernstein, Ilene 54 Burton, Michael 58, 122 Christianity 35, 37, 51 Bethlem Royal Hospital Archives Bush, George W. 38 Chromadoris, Vibrata 120 and Museum 14 Bwiti 8 chromium picolinate 108 Bialynickiego-Birula, Teodora 13 chuchuhuasi 109 Big Basin State Park 121 C Chung, Wang 35, 37 Big House Red 150 Cielo Ethnobotanicals 24, 26 C.H., CA 24 BitTorrent 120 cigarette 139 cacao 72 Bizony, Piers 120 cinnamoyl-ecgonine 110 caffeine 23, 25, 42, 109 black cohosh 107 Cake circumdatin 151 Blackmore, Susan (the band) 153 103, 120 Calderón, Eduardo cis-cinnamoylcocaine 110 52, 53 City Lights Bookstore bladderwrack 107 California Institute of Integral 14 Blake, William 63 Clarkia Extra Strong 107 Studies 73 Blasphemo 37 clavohuasca 109 Callaway, Jace 112 Bleuler, Manfred 14 CLEAN-UP Act (H.R. 834) 30 camphor 140 Bockbier 32 Clear 120 cancer 90, 93 Bohm, David 74 clonidine 111 Cané, Ralph E. 42 Bohm, Sheelo 119 cluster headaches 83, 85, 86, 87, 89, Cannabis 1, 2, 14, 22, 25, 54, 55, 56, Bohnlich, Uriel 36, 37, 38 91, 92, 93 57, 96, 97, 101, 119, 124, 145, 153, Bohr, Niels 64 Clusterbusters 83 154, 155 Boire, Richard Glen 29, 124 Coalition for Cosmic Consciousness Cannabis Culture magazine 96, 97, 100, Bölsche, Wilhelm 36 153 101 Bön 35 Coca und Kokain: Ethnomedizin, Kunst Cannabis seeds 99 Boniface, Saint 35, 37 und Chemie (by Ott & Rätsch) carcinogen 108 Bonny, Helen 20 110 Case, Justin 28, 46, 109, 110, 111, 147 Booh Bah 70 cocaine 6, 10, 59, 75, 110, 148 Catapres 111 Book of Kells 69 cochineal 60 catawa bark 139 BOOM Festival 29 Code of Federal Regulations 106, 107 Catha edulis 149 Boon, Marcus 13 Codex Alimentarius Committee 106, catheter 149 Bosch, Hieronymus 63 108 cathinone 149 Botanical Preservation Corps 109 coffee 96, 139 Catholic 61, 68, 95 Botox 126 Cold Beer Blues Bar 135 caustic potash 50 brain damage 9 Collins, D.J. 115 Cellphedia 120 brain implants 125 Center for Educational Research Colombian coca 75 brain stimulators, deep- 125 Columbus, Christopher 70 and Development 3 Brandy 69 comfrey 107 Centre for the Mind 63 Bravo Trading Ltd. 123 Comings, Mark 29 century plant 14 Brazil 63 Condamine, Charles-Marie de La 41 Cereus peruvianus 126 Breezes 154, 156, 158 Confessions of a Dope Dealer (by CH Cl 94 “Brent’s Guide to Proglumide 2 2 Norberg) 121 chacapa 135, 137, 140, 143 Therapy” 151 Congress of the International chacruna 138 brine 94 Walter Benjamin Association Chagall, Marc 64 British Patent #1374343 55 14 Chamberlain, Claude 22 Broadley, K.J. 105 Conroy, John 101 Chamberlain, Dean 121, 152 Broadway Books 125 controlled substance analogue 150 Chapel of Sacred Mirrors 74, 153, Brod, Thomas M. 121, 152 Controlled Substance Analogue 156, 158 Brooklyn Bridge 131 Enforcement Act 59 Charalampous, K.D. 41 Brother John 61, 63, 68 Controlled Substances Act 59 Charley’s Greenhouse 56 Brown, Joel 3 Cooper Union College of Art 129 Chavin 41 Brown, Luke 29, 120, 121, 152 coramine 84 Cheap Vaporizer 57 Brown University 87 Corazon, Linda 120 Chencho 60, 61, 66 BRT, Belgium 147 Corina 137, 138, 139, 143 Chepa 135, 138, 140, 141, 143 Bt2CGMP 151 CoSM: Journal of Visionary Culture 74 160 THE ENTHEOGEN REVIEW, POB 19820, SACRAMENTO, CA 95819-0820, USA VOLUME XIV, NUMBER 2 WINTER SOLSTICE 2005 CosmiKiva Sanctuary 29 dimenhydrinate 7 EEG 7 Coste, J. 94 dimethyltryptamine (see DMT) Eggers, Eberhard 20 Cotler, Irwin 97 Diode Array Detector 113 ego death 140 Cousto, Hans 29 Diogenes of Apollonia 35, 37 eidetic imagery 17 creativity 18, 19 dipropyltryptamine (see DPT) Eisner, Betty 10, 21 Crillon Importers Ltd. 107 DIPT 59 Elavil 111 Cristian 62 Disney, Walt 70 elder tree 31 Crowley, Mike 120, 121 dizziness 104, 105 Eleusis 84 curandera 69, 72, 96 DMSO 110 elves 38 curandero 53, 64, 66, 67, 68, 134 DMT 27, 46, 55, 56, 57, 89, 92, 94, emergency room 149 Curtis, April 58, 122 109, 111, 112, 113, 114, 115, 116, Emery Direct Seeds 96, 99, 100, 101 Cybele 37 117, 118, 125 Emery, Marc 1, 3, 4, 11, 96, 97, 98, 99, cyclo-oxygenase 111 DNA 140 100, 101 cytotoxic 54 Dobelis, I.N. 108 empathogenic 28 Dobkin de Rios, Marlene 17, 121, 152 Empedocles 35 D Doblin, Rick 83, 84, 85, 87, 88, 89, Encyclopedia of Psychoactive Plants (by 90, 91, 92, 93, 119 Rätsch) 126 D.P., CA 111 Doc, IN 27 enema 41, 42, 45, 46, 48, 110 Da Paz, Gamo 73 doctors, the 135, 137, 141, 143 Enlightenment, anti- 36 Da Vinci, Leonardo 63 Donar (the god of thunder) 35 Entheogen Law Reporter, The 124 Dactylopius coccusa 60 dopamine 10, 148 Entheogen Review, The 41, 55, 56, 57, Dadd, Richard 14 Downs, James 122 81, 94, 111, 122, 123, 149, 157 Damer, Bruce 68, 69, 119 DP, CA 112 Entheogen: Awakening the God Within DARE 3 DPT 46, 57, 91, 92 119 Davidson, Kris 121 Dr. Benway 122 Entheogene Blätter 29, 31 Davies, Paul 152 Dr. Wily 103 Entheogenesis 96 Davis, Erik 70, 72, 119 Dramamine® 7 EntheoVision 2 29 Davis, Floyd 117 Draw-A-Man / Draw-A-Person 15, 20 EnthogenUK 46 Dbotany 75, 110 dream man 104 ephedra 107 De Onorato, A.C. 17 dream symbolism 64 Epling, C. 95 De Keijzer, Fred 21 drowsiness 104 ereriba 104, 105 De Beer 105 Drug Policy Alliance 30, 73, 153 ergot 34, 54, 83 DEA (Drug Enforcement Administra- Dryer, Donna 86 Eric (rip off vendor) 55 tion) 58, 59, 84, 93, 94, 96, 99, Dugas, D.R.
Recommended publications
  • 50. Down the Rabbit Hole with Mitch Schultz, Part 1 Recorded on 12Th August, 2019 in Byron Bay, Australia

    50. Down the Rabbit Hole with Mitch Schultz, Part 1 Recorded on 12Th August, 2019 in Byron Bay, Australia

    50. Down the Rabbit Hole with Mitch Schultz, Part 1 Recorded on 12th August, 2019 in Byron Bay, Australia. With Special Guest, Mitch Schultz. Future Sense is a podcast edited from the radio show of the same name, broadcast on BayFM in Byron Bay, Australia, at www.bayfm.org. Hosted by Nyck Jeanes and well-known international futurist, Steve McDonald, Future Sense provides a fresh, deep analysis of global trends and emerging technologies. How can we identify the layers of growth personally, socially and globally? What are the signs missed; the truths being denied? Political science, history, politics, psychology, ancient civilisations, alien contact, the new psychedelic revolution, cryptocurrency and other disruptive and distributed technologies, and much more. This is Future Sense. Nyck: You're now tuned to Future Sense with myself, Nyck Jeanes, and my co-host Steve McDonald. Good morning, Steve. Steve: Good morning, Nyck. Nyck: And it's a great pleasure to welcome back to the studio—and we just worked it out, it's been like a year and a half—our friend Mitch Schulz from the US, the Texan Elf. Mitch: Thanks for having me back, guys. Steve: Welcome back, Mitch. Nyck: It's great to have you back here. You've just arrived from Austin, Texas. Mitch: I have, and always great to be back here. I look forward to a little bit of time with you guys. Stuff's happening. 1 This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ Nyck: A bit of a sketch before we play the first track, of what we're going to be doing today.
  • The Effects of Low Dose Lysergic Acid Diethylamide Administration in a Rodent Model of Delay Discounting

    The Effects of Low Dose Lysergic Acid Diethylamide Administration in a Rodent Model of Delay Discounting

    Western Michigan University ScholarWorks at WMU Dissertations Graduate College 6-2020 The Effects of Low Dose Lysergic Acid Diethylamide Administration in a Rodent Model of Delay Discounting Robert J. Kohler Western Michigan University, [email protected] Follow this and additional works at: https://scholarworks.wmich.edu/dissertations Part of the Biological Psychology Commons Recommended Citation Kohler, Robert J., "The Effects of Low Dose Lysergic Acid Diethylamide Administration in a Rodent Model of Delay Discounting" (2020). Dissertations. 3565. https://scholarworks.wmich.edu/dissertations/3565 This Dissertation-Open Access is brought to you for free and open access by the Graduate College at ScholarWorks at WMU. It has been accepted for inclusion in Dissertations by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. THE EFFECTS OF LOW DOSE LYSERGIC ACID DIETHYLAMIDE ADMINISTRATION IN A RODENT MODEL OF DELAY DISCOUNTING by Robert J. Kohler A dissertation submitted to the Graduate College In partial fulfillment of the requirements for the degree of Doctor of Philosophy Psychology Western Michigan University June 2020 Doctoral Committee: Lisa Baker, Ph.D., Chair Anthony DeFulio, Ph.D. Cynthia Pietras, Ph.D. John Spitsbergen, Ph.D. Copyright by Robert J. Kohler 2020 THE EFFECTS OF LOW DOSE LYSERGIC ACID DIETHYLAMIDE ADMINISTRATION IN A RODENT MODEL OF DELAY DISCOUNTING Robert J. Kohler, Ph.D. Western Michigan University, 2020 The resurgence of Lysergic Acid Diethylamide (LSD) as a therapeutic tool requires a revival in research, both basic and clinical, to bridge gaps in knowledge left from a previous generation of work. Currently, no study has been published with the intent of establishing optimal microdose concentrations of LSD in an animal model.
  • Multidisciplinary Association for Psychedelic Studies

    Multidisciplinary Association for Psychedelic Studies

    MULTIDISCIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES VOLUME X NUMBER 3 PSYCHEDELICS & CREATIVITY 2 m a p s • v o l u m e X n u m b e r 3 • c r e a t i v i t y 2 0 0 0 Creativity 2000 MAPS (Multidisciplinary Association for 1 Introductions Psychedelic Studies) is a membership-based Rick Doblin, Ph.D., Jon Hanna and Sylvia Thyssen organization working to assist psychedelic 4 Psychedelics and the Creation of Virtual Reality researchers around the world design, obtain Excerpted from an interview with Mark Pesce governmental approval, fund, conduct and report on psychedelic research in humans. 6 Visionary Community at Burning Man Founded in 1986, MAPS is an IRS approved By Abrupt 501 (c)(3) non-profit corporation funded 9 The Creative Process and Entheogens by tax-deductible donations. MAPS has Adapted from The Mission of Art previously funded basic scientific research By Alex Grey into the safety of MDMA (3,4-methylene- 12 Left Hand, Wide Eye dioxymethamphetamine, Ecstasy) and has By Connor Freff Cochran opened a Drug Master File for MDMA at the U.S. Food and Drug Administration. MAPS is 17 Huxley on Drugs and Creativity Excerpted from a 1960 interview for The Paris Review now focused primarily on assisting scientists to conduct human studies to generate 18 Ayahuasca and Creativity essential information about the risks and By Benny Shanon, Ph.D. psychotherapeutic benefits of MDMA, other 20 MAPS Members Share Their Experiences psychedelics, and marijuana, with the goal Anecdotes by Abram Hoffer, M.D., Ph.D., FRCP(C), of eventually gaining government Dean Chamberlain, Dan Merkur, Ph.D., Sam Patterson, approval for their medical uses.
  • A General Approach to the Screening and Confirmation of Tryptamines And

    A General Approach to the Screening and Confirmation of Tryptamines And

    Available online at www.sciencedirect.com Talanta 74 (2008) 512–517 A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation Bo-Hong Chen a, Ju-Tsung Liu b, Wen-Xiong Chen a, Hung-Ming Chen a, Cheng-Huang Lin a,∗ a Department of Chemistry, National Taiwan Normal University, 88 Sec. 4, Tingchow Road, Taipei, Taiwan b Forensic Science Center, Military Police Command, Department of Defense, Taipei, Taiwan Received 6 March 2007; received in revised form 12 June 2007; accepted 13 June 2007 Available online 19 June 2007 Abstract Certain characteristic fragmentations of tryptamines (indoleethylamine) and phenethylamines are described. Based on the GC–EI/MS, LC–ESI/ MS and MALDI/TOFMS, the mass fragmentations of 13 standard compounds, including ␣-methyltryptamine (AMT), N,N-dimethyltryptamine (DMT), 5-methoxy-␣-methyltryptamine (5-MeO-AMT), N,N-diethyltryptamine (DET), N,N-dipropyltryptamine (DPT), N,N-dibutyltryptamine (DBT), N,N-diisopropyltryptamine (DIPT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), 5-methoxy-N,N-diisopropyltryptamine (5-MeO- DIPT), methamphetamine (MAMP), 3,4-methylenedioxyamphetamine (3,4-MDA), 3,4-methylenedioxymethamphetamine (3,4-MDMA) and 2- methylamino-1-(3,4-methylenedioxyphenyl)butane (MBDB), were compared. As a result, the parent ions of these analytes were hard to be obtained by GC/MS whereas the protonated molecular ions can be observed clearly by means of ESI/MS and MALDI/TOFMS. Furthermore, two major + + + + characteristic fragmentations, namely and ␣-cleavage ([M +H] → [3-vinylindole] ) and ␤-cleavage ([M +H] → [CH2N RN1RN2]), are produced when the ESI and MALDI modes are used, respectively. In the case of ESI/MS, the fragment obtained from ␣-cleavage is the major process.
  • ELCOCK-DISSERTATION.Pdf

    ELCOCK-DISSERTATION.Pdf

    HIGH NEW YORK THE BIRTH OF A PSYCHEDELIC SUBCULTURE IN THE AMERICAN CITY A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Department of History University of Saskatchewan Saskatoon By CHRIS ELCOCK Copyright Chris Elcock, October, 2015. All rights reserved Permission to Use In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, for scholarly purposes may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make other use of material in this thesis in whole or part should be addressed to: Head of the Department of History Room 522, Arts Building 9 Campus Drive University of Saskatchewan Saskatoon, Saskatchewan S7N 5A5 Canada i ABSTRACT The consumption of LSD and similar psychedelic drugs in New York City led to a great deal of cultural innovations that formed a unique psychedelic subculture from the early 1960s onwards.
  • The Entheogen Review , Pob 19820, Sa Cramento , Ca 95819-0820, Usa  161 Vol Ume X, Number 4 Winter Solstice 2001

    The Entheogen Review , Pob 19820, Sa Cramento , Ca 95819-0820, Usa  161 Vol Ume X, Number 4 Winter Solstice 2001

    VOL UME X, NUMBER 4 WINTER SOLSTICE 2001 Index Symbols Age of Entheogens & The Angels’ Dictionary, Analog Act 84, 85 The 154 Anand, Margot 67, 154 ∞Ayes 32, 49, 50, 51 age regression 89 Anderson, E.F. 106 1,4-butanediol 84 Aguaruna Indians 10 Anderson, Rocky 41 1984 155 Aguirre, G., L.E. 3, 5, 6 Anderson, Sherry 156 2001 52 Agurell, S. 57, 58, 106 Andrews, S. 86 2C-B 22, 28, 118 ahpí 7 anesthetize 21 2C-D 20 ajucá 6 angico 6 2C-I 20 Akashic record 54 angicos brancos 6 2C-T-2 20, 22, 90 Al-Queda terrorists 123 angicos pretos 6 2C-T-4 20 Alarcón, R. 5 angiquín 6 2C-T-7 20, 85, 89, 90, 94, 105, 114 Alchemind Society, The 42, 76, 112 angiquinho 6 4-acetoxy-DET 88, 89, 90, 92, 93, 96 alcohol Angraecum fragrans 86 4-acetoxy-DIPT 29, 30, 88, 90, 91, 93 38, 52, 74, 84, 98, 99, 134, 145, 146 Anon. 151 4-hydroxy-αMT 139 alcoholic beverages 86 anonymous remailer 123 4-hydroxy-DET 88, 89, 139 Aldrich 83 anthraquinones 86 4-hydroxy-DMT 88 alfalfa 129 anti-cholinergic-like central effect 150 4-hydroxy-DPT 139 alien 32, 50, 53 anti-depressant 28 5-MeO-αMT 148 alien robots 52 anti-inflammatory 86 5-MeO-DIPT 90, 94 AllChemical Arts (conference) 115 anti-marijuana laws 46 5-MeO-DMT Allen, John W. 112 anti-nausea medications 28 1, 5, 25, 84, 89, 99, 101, 102, 103, allergy preparations 28 antibacterial 135 118, 126, 148 Alli, Antero 114 antibiotic 28 5-methoxytryptamine 150 Allison 156 antidiarrheal 104 Alpert, Richard 34 antispasmatic 28 A alpha 140, 141, 142, 143, 144, 145 Antonil, André João 4 Aardvark, David α-MT 148 ants 151 α 21, 27, 28, 30, 34, 51,
  • M a P S • V O L U M E X I I I N U M B E R 2

    M a P S • V O L U M E X I I I N U M B E R 2

    m a p s • v o l u m e x i i i n u m b e r 2 • w i n t e r 2 0 0 3 1 2 m a p s • v o l u m e x i i i n u m b e r 2 • w i n t e r 2 0 0 3 Divine Spark The cover of this MAPS bulletin is an image from visionary artist Alex Grey’s triptych Holy Fire, which was inspired by one of Alex’s early MDMA experiences. We thought it was an appropriate choice to ex- press our emotions at obtaining Institutional Review Board (IRB) approval for Dr. Mithoefer's MAPS-sponsored MDMA/PTSD study (see page 7). The rest of the images on this page and on the back cover are from the 2003 Burning Man Festival, at which MAPS provided psychedelic emergency services. (Article on page 28). In the photo above, members of the Fire Conclave open the festivities at the Burning of the Man, the climax of the week-long festival. The photo below depicts the more somber burning of the Temple of Honor, at which Burning Man participants remember loved ones by leaving notes and tokens inside. As the temple burned, MAPS president Rick Doblin threw in the fire the original copies of the last set of documents about protocol design issues exchanged between MAPS and the IRB. This symbolized his hopes that we would finally move beyond the paperwork of the approval process to the therapeutic work of the study itself.
  • Hallucinogens: an Update

    Hallucinogens: an Update

    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Hallucinogens: An Update 146 U.S. Department of Health and Human Services • Public Health Service • National Institutes of Health Hallucinogens: An Update Editors: Geraline C. Lin, Ph.D. National Institute on Drug Abuse Richard A. Glennon, Ph.D. Virginia Commonwealth University NIDA Research Monograph 146 1994 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGEMENT This monograph is based on the papers from a technical review on “Hallucinogens: An Update” held on July 13-14, 1992. The review meeting was sponsored by the National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other material in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or company.
  • Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither Jseit005@Fiu.Edu

    Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected]

    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 4-25-2018 Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances Joshua Zolton Seither [email protected] DOI: 10.25148/etd.FIDC006565 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Chemistry Commons Recommended Citation Seither, Joshua Zolton, "Application of High Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances" (2018). FIU Electronic Theses and Dissertations. 3823. https://digitalcommons.fiu.edu/etd/3823 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida APPLICATION OF HIGH RESOLUTION MASS SPECTROMETRY FOR THE SCREENING AND CONFIRMATION OF NOVEL PSYCHOACTIVE SUBSTANCES A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in CHEMISTRY by Joshua Zolton Seither 2018 To: Dean Michael R. Heithaus College of Arts, Sciences and Education This dissertation, written by Joshua Zolton Seither, and entitled Application of High- Resolution Mass Spectrometry for the Screening and Confirmation of Novel Psychoactive Substances, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Piero Gardinali _______________________________________ Bruce McCord _______________________________________ DeEtta Mills _______________________________________ Stanislaw Wnuk _______________________________________ Anthony DeCaprio, Major Professor Date of Defense: April 25, 2018 The dissertation of Joshua Zolton Seither is approved.
  • Designer Drugs: a Review

    Designer Drugs: a Review

    WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Chavan et al. World Journal of Pharmacy and Pharmaceutical Sciences SJIF Impact Factor 5.210 Volume 4, Issue 08, 297-336. Review Article ISSN 2278 – 4357 DESIGNER DRUGS: A REVIEW Dr. Suyash Chavan,MBBS*1 and Dr. Vandana Roy2 1MD, Resident Doctor, Department of Pharmacology, Maulana Azad Medical College, New Delhi. 2MD, PhD Professor, Department of Pharmacology, Maulana Azad Medical College, New Delhi. ABSTRACT Article Received on 25 May 2015, Designer drugs‟ are psychoactive substances that mimic the effects of Revised on 16 June 2015, other banned illicit drugs but evade detection by law enforcing Accepted on 07 July 2015 agencies. This is because of modifications in the structure of the original psychoactive molecule. Originally developed as a way to *Correspondence for evade existing drug laws in the late 1960s, the synthesis and use of Author designer drugs has increased dramatically. They are advertised with Dr. Suyash Chavan innocuous names and are sold mostly over the internet, discreet outlets MD, Resident Doctor, Department of and at entertainment clubs. Victims may exhibit symptoms similar to Pharmacology, Maulana the effects of the illegal drug that these synthetic drugs mimic, Azad Medical College, however, the exact culprit drug is not detected due to structural New Delhi. modifications in the new drug. Overdose of these drugs may lead to serious adverse effects that can be life threatening. Understanding the pharmacology and toxicology of these agents is essential to facilitate their detection and to provide better medical care for patients suffering from adverse effects due to their consumption.
  • Newer Unregulated Drugs Look-Up Table

    Newer Unregulated Drugs Look-Up Table

    Newer Unregulated Drugs Look-up Table List Name Chemical Name/AKA Type of drug Notes Stimulant Regulation under MDA (Sch. 1 or TCDO) Stimulant/Hallucinogen Regulation under MDA (Sch. 2-5) Hallucinogen Regulated by PSA Depressant Exempt Cannabinoid Uncertain/requires clarification 1P-LSD 1-propionyl-lysergic acid diethylamide Hallucinogen An LSD analogue that side-stepped MDA and was on sale as an NPS; now covered by the PSA. 2-AI 2-Aminoindane Stimulant, amphetamine analogue Reported in the UK in 2011 by the Forensic Early 2-MAI N-methyl-2-Aminoindane Warning System (FEWS). Had been on sale via number MMAI of online stores; covered by PSA. 2-MeO-ketamine Methoxyketamine Related to methoxetamine so a relative Believed to have been made a CD at the same time as Methoxieticyclidine of ketamine – i.e. a dissassociative Methoxetamine anaesthetic hallucinogen 2C-B-BZP (1-(4-bromo-2,5- Piperazine family; stimulant Class B dimethoxybenzyl)piperazine) 2-DPMP Desoxypipadrol stimulant Strong and long acting stimulant; reported duration of 2-diphenylmethylpiperidine effect 24-28hrs or more and effective at very low doses. Had been on sale in the UK and cropped up in branded “Ivory Wave” and in other compounds. Linked to fatalities. Class B, Sch1. 2-NE1 APICA Synthetic cannabinoid receptor agonist 3rd generation SCRA. Covered by PSA SDB-001 N-(1-adamantyl)-1-pentyl-1H-indole-3- carboxamide 3-FPM Phenzacaine Stimulant, euphoriants Sibling of the controlled drug Phenmetrazine. Emerged PAL-593 2015. Covered by PSA 2-(3-fluorophenyl)-3-methylmorpholine 3-hydroxyphenazepam Benzo, GABA-nergic PSA 3-MeO-PCE (3-methoxyeticyclidine) Related to methoxetamine so a relative Probably regulated under the same clause that made of ketamine – i.e.
  • NIDA Drug Supply Program Catalog, 25Th Edition

    NIDA Drug Supply Program Catalog, 25Th Edition

    RESEARCH RESOURCES DRUG SUPPLY PROGRAM CATALOG 25TH EDITION MAY 2016 CHEMISTRY AND PHARMACEUTICS BRANCH DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES NATIONAL INSTITUTE ON DRUG ABUSE NATIONAL INSTITUTES OF HEALTH DEPARTMENT OF HEALTH AND HUMAN SERVICES 6001 EXECUTIVE BOULEVARD ROCKVILLE, MARYLAND 20852 160524 On the cover: CPK rendering of nalfurafine. TABLE OF CONTENTS A. Introduction ................................................................................................1 B. NIDA Drug Supply Program (DSP) Ordering Guidelines ..........................3 C. Drug Request Checklist .............................................................................8 D. Sample DEA Order Form 222 ....................................................................9 E. Supply & Analysis of Standard Solutions of Δ9-THC ..............................10 F. Alternate Sources for Peptides ...............................................................11 G. Instructions for Analytical Services .........................................................12 H. X-Ray Diffraction Analysis of Compounds .............................................13 I. Nicotine Research Cigarettes Drug Supply Program .............................16 J. Ordering Guidelines for Nicotine Research Cigarettes (NRCs)..............18 K. Ordering Guidelines for Marijuana and Marijuana Cigarettes ................21 L. Important Addresses, Telephone & Fax Numbers ..................................24 M. Available Drugs, Compounds, and Dosage Forms ..............................25